U.S. Fund A Shares (without sales charge) posted a return of -0.04% in second quarter of 2026. Read more here.
THC raised its 2026 outlook after Q2 earnings and revenues beat expectations, driven by strong same-facility growth and disciplined expense management.
Our top performer in the second quarter was ICON plc, which gained 57%. Our largest detractor during the quarter was Intercontinental Exchange, which declined 21.7%. Read more here.
Seth Klarman's Baupost Group just revealed its five largest stock positions, and the list includes a little-known industrial distributor posting explosive earnings growth alongside household names ble
The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.
HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.
EW beats Q2 earnings and revenue estimates as strong TAVR demand, and mitral and tricuspid therapy adoption lift results and guidance.
Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.
View interactive chart, options flow, and AI analysis for ELV on Zorveq Finance.
Open ELV Chart & Analysis →